Optimizing Quality System Procedures for Compliance and Efficiency for Pharmaceutical and Medical Device industries

Structured Quality System Procedures (QSPs) are essential in the pharmaceutical and medical device industries for ensuring regulatory compliance, product safety, and operational efficiency. This study investigates best practices for QSP development, focusing on clarity, regulatory alignment, stakeholder collaboration, and risk based approaches. Analysis of standards such as Health Canada’s Food and Drugs Act (Health Canada, 2023), FDA 21 CFR Part 820 (Medical Devices; Quality System Regulation Amendments, 2024), ISO 13485, and ICH Q10 reveals their critical role in mitigating noncompliance risks and enhancing audit outcomes.